Regional News
TJ Biopharma Doses First Patient in Phase 1 Trial of TJ-C64B, a CLDN6x4-1BB Bispecific Antibody for CLDN6-Positive Solid Tumors
- TJ-C64B is an internally developed CLDN6 × 4-1BB bispecific antibody for which TJ Biopharma retains global rights, and is among the leading programs in this class globally - First patient dosing marks a key milestone for TJ Biopharma's next-generation innovation pipeline HANGZHOU, China, Oct....
2026-10-26 20:00
2
140th Canton Fair: Circular Economy in Products and Practice
GUANGZHOU, China, Oct. 26, 2026 /PRNewswire/ -- As sustainability moves from a corporate commitment to a business imperative, the principles of the circular economy are becoming increasingly visible across both products and industry practices. This shift can also be observed at the 140th Canton F...
2026-10-26 19:00
334
Radar Tires Joins Forces with the 8-Division Boxing World Champion Manny Pacquiao's Basketball League, the MPBL, to Drive Youth Forward Through Sport in the Philippines
Global tire brand Radar Tires becomes Official Partner of Manny Pacquiao's Maharlika Pilipinas Basketball League (MPBL), supporting his mission to empower young Filipinos through opportunity in sport and create a lasting and positive impact on society. SINGAPORE, Oct. 26, 2026 /PRNewswire/ -- Gl...
2026-10-26 18:59
430
The 26th "Blue Fair" Kicks Off in Qingdao
QINGDAO, China, Oct. 26, 2026 /PRNewswire/ -- A report from Iqingdao. On October 22, the 2026 Qingdao International Talent Innovation and Entrepreneurship Week and the 26th "Blue Fair" opened officially. Under the themeGathering Talent and Strength for a Shared Innovative Future, the event broug...
2026-10-26 18:23
424
WuXi AppTec Delivers Strong Q1-Q3 2026 Results and Further Raises Full-Year Guidance, Driven by Greater Success of Multiple Customers' Products and CRDMO Model
SHANGHAI, Oct. 26, 2026 /PRNewswire/ -- WuXi AppTec (Stock Codes: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced financial results for the first three quarters ending September 30, 2026 ("Reporting Peri...
2026-10-26 17:25
1004
Innovent Announces NMPA Acceptance of a New Indication Application of Sintilimab for the Treatment of Advanced Melanoma
SAN FRANCISCO and SUZHOU, China, Oct. 26, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...
2026-10-26 17:18
987
Abu Dhabi Invests In The Next Generation Of Musical Talent With A New Dedicated Institution For The Youth Orchestra Abu Dhabi
A long-term pathway for young musicians through free access to world-class music education. ABU DHABI, UAE, Oct. 26, 2026 /PRNewswire/ -- The Department of Culture and Tourism – Abu Dhabi (DCT Abu Dhabi) is proud to announce the establishment of a dedicated institution for the Youth Orchestra Ab...
2026-10-26 16:57
759
Guosen Securities Outlines Priorities for China's Capital Markets Under 15th Five-Year Plan
Market stability, support for innovation and stronger regulatory oversight to shape capital market development through 2030 SHENZHEN, China, Oct. 26, 2026 /PRNewswire/ -- Guosen Securities, one of China's leading securities firms and investment banks, expects the country's capital markets to mak...
2026-10-26 16:28
744
Chartis Names Linkurious, a Nuix Company, a Category Leader in AML Transaction Monitoring
PARIS, Oct. 26, 2026 /PRNewswire/ -- Linkurious, a Nuix company and a pioneer in graph-powered decision intelligence,today announced it was named a Category Leader in the Chartis Research RiskTech Quadrant® for AML Transaction Monitoring Solutions, 2026. The recognition marks a significant advan...
2026-10-26 16:00
793
111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
SHANGHAI, Oct. 26, 2026 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), comprising three independent directors, Mr. Jian Sun, who is the chairman of...
2026-10-26 16:00
1090
SCIA Hosts the First FDI Moot Global Finals in China, Strengthening Shenzhen's Position as a Global Arbitration Hub
SHENZHEN, China, Oct. 26, 2026 /PRNewswire/ -- A news report from
chinadaily.com.cn:
2026-10-26 15:31
896
Canton Fair Expands Human-Centered Approach Through Shared Experiences, Culture and Dialogue
GUANGZHOU, China, Oct. 26, 2026 /PRNewswire/ -- The 140th Canton Fair has entered Phase 2 (October 23–27) with vibrant lion dances and Yingge dance performances welcoming exhibitors and buyers worldwide. As China's longest-running trade fair, it has evolved into a venue for cultural exchange, wh...
2026-10-26 15:23
894
Amflow Announces Sales Availability for Two of Its Most Anticipated Models
The Amflow TL Now Available for Purchase Globally, and the Amflow PR Now
Available in the US
SHENZHEN, China, Oct. 26, 2026 /PRNewswire/ -- Amflow
2026-10-26 15:00
1320
ESMO 2026 | Professors Jie Wang, Zhijie Wang and Jianchun Duan's Team Reports 95.2% Disease Control With LK101 Combination Maintenance Therapy in Advanced NSCLC
BEIJING, Oct. 25, 2026 /PRNewswire/ -- On October 24, 2026, in Madrid, Spain, the team of Professors Jie Wang, Zhijie Wang and Jianchun Duan at the Cancer Hospital, Chinese Academy of Medical Sciences, presented Phase 1b/2a results in a Rapid Oral session at ESMO Congress 2026. The study evaluate...
2026-10-26 11:27
2567
Results of CARsgen's Satri-cel for Adjuvant Treatment for Gastric Cancer Presented at ESMO Congress 2026
SHANGHAI, Oct. 25, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the preliminary positive research results of the investigator-initiated trial (CT041-CG4010, NCT06857786) in China o...
2026-10-26 08:30
4472
2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein
* The data showcased are from three Phase 1b clinical studies of IBI363/TAK-928 in first-line NSCLC, first-line G/GEJA, and immunotherapy-resistant lung adenocarcinoma, further supporting its potential clinical value across treatment settings. SAN FRANCISCO and SUZHOU, China, Oct. 25, 2026 /PR...
2026-10-26 08:00
2695
2026 ESMO | Innovent Announcement Phase 2 Data Presentation for IBI354 (HER2 ADC) In First-line Treatment of Breast Cancer
SAN FRANCISCO and SUZHOU, China, Oct. 25, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative drugs for major diseases including oncology, autoimmune, metabol...
2026-10-25 14:00
4662
2026 ESMO | Innovent Presented Phase 1 Study Data for IBI3001, a First-in-Class EGFR/B7H3 Bispecific ADC
SAN FRANCISCO and SUZHOU, China, Oct. 25, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative drugs for major diseases including oncology, autoimmune, metabol...
2026-10-25 14:00
4339
Zhejiang Wenda Pharma Announces Positive Results from Phase II Trial of Oral BET Inhibitor NHWD-870 HCl at the 2026 ESMO Annual Meeting
SHAOXING, China, Oct. 24, 2026 /PRNewswire/ -- At the 2026 ESMO Annual Meeting, Zhejiang Wenda Pharmaceutical Technology Co., Ltd. ("Wenda Pharma") will publish the phase II clinical trial data for NHWD-870HCl, an oral BET inhibitor, in Chinese patients with advanced NUT carcinoma (NC). In this...
2026-10-25 09:00
5354
World Young Scientist Summit 2026 Opens in Wenzhou, Zhejiang
WENZHOU, China, Oct. 24, 2026 /PRNewswire/ -- This is a report by China Daily: On October 24, the World Young Scientist Summit 2026 opened in Wenzhou, Zhejiang. The event is hosted by the China Association for Science and Technology (CAST), the Zhejiang Provincial People's Government, and the Wor...
2026-10-24 22:37
3267
Week's Top Stories
Most Reposted
HLB Customers Can Now Scan & Pay in China with HLB QR Pay
[Picked up by 294 media titles]
2026-10-22 22:35
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 283 media titles]
2026-10-19 13:18
TCL Zhonghuan Powers India's Energy Transition with PV Innovations at REI Expo 2026
[Picked up by 281 media titles]
2026-10-23 21:52
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 278 media titles]
2026-10-21 15:00
DayOne Supports NVIDIA DSX POD Reference Design, Advancing Standardized Infrastructure for AI
[Picked up by 271 media titles]
2026-10-22 11:55Most Read
Hi3D V1.0 Goes Open Source: The First Production-Validated Open-Source AI 3D Model
2026-10-23 23:30
32774
Home 3D Printers are More Accessible Than Ever This Black Friday with Bambu Lab
2026-10-22 17:00
29680
BeautyPlus Web Launches Halloween Photo Booth With Behind-the-Scenes Video Export
2026-10-23 01:00
27370
Cuttable Unveils Next-Generation AI Advertising Platform as U.S. Expansion Accelerates
2026-10-24 00:00
25816